Easy strategy to protect antimicrobial peptides from fast degradation in serum

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 4003-4005

  Knappe, Daniel ^a   Henklein, Petra ^b   Hoffmann, Ralf ^a   Hilpert, Kai ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 GUANIDINO PROPIONIC ACID; AMINO ACID DERIVATIVE; ARGININE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DEGRADATION; DRUG STABILITY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ARGININE; DRUG STABILITY; MICE; MICROBIAL SENSITIVITY TESTS; SERUM;

EID: 77956125592     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00300-10     Document Type: Article

References (6)

1. Fritsche, T. R., P. R. Rhomberg, H. S. Sader, and R. N. Jones. 2008. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. J. Antimicrob. Chemother. 61:1092-1098.
2. Henklein, P., and T. Bruckdorfer. 2008. Shorter arginine homologues to stabilize peptides towards tryptic digestion. Chem. Today/Chim. Oggi. 26:12-15.
3. Hilpert, K., R. Volkmer-Engert, T. Walter, and R. E. W. Hancock. 2005. High-throughput generation of small antibacterial peptides with improved activity. Nat. Biotechnol. 23:1008-1012.
4. Sader, H. S., K. A. Fedler, R. P. Rennie, S. Stevens, and R. N. Jones. 2004. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Antimicrob. Agents Chemother. 48:3112-3118.
5. Wiegand, I., K. Hilpert, and R. E. W. Hancock. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat. Protocols 3:163-175.
6. Zelezetsky, I., S. Pacor, U. Pag, N. Papo, Y. Shai, H. G. Sahl, and A. Tossi. 2005. Controlled alteration of the shape and conformational stability of alphahelical cell-lytic peptides: effect on mode of action and cell specificity. Biochem. J. 15:177-188. (Pubitemid 41192243)